-
The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
(PA-18-037)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Multiple dates, see announcement.
-
The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional)
(PA-18-040)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Multiple dates, see announcement.
-
The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional)
(PA-18-054)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Multiple dates, see announcement.
-
Multidisciplinary Research in Vulvodynia (R01 Clinical Trial Optional)
(PA-18-089)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)
(PA-18-096)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)
(PA-18-137)
National Institute of Nursing Research
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Personalized Strategies to Manage Symptoms of Chronic Illness (R01 Clinical Trial Optional)
(PA-18-138)
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.,Standard dates apply by 5:00 PM local time of applicant organization
-
Innovative Questions in Symptom Science and Genomics (R01 Clinical Trial Optional)
(PA-18-139)
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.,Standard dates apply by 5:00 PM local time of applicant organization
-
Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01 Clinical Trial Optional)
(PA-18-140)
National Institute of Nursing Research
National Center for Complementary and Integrative Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)
(PA-18-141)
National Institute of Nursing Research
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01 Clinical Trial Optional)
(PA-18-142)
National Institute of Nursing Research
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
-
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R01 Clinical Trial Optional)
(PA-18-143)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Health Promotion Among Racial and Ethnic Minority Males (R01 Clinical Trial Optional)
(PA-18-144)
National Institute of Nursing Research
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R01 Clinical Trial Optional)
(PA-18-145)
National Institute of Nursing Research
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01 Clinical Trial Optional)
(PA-18-146)
National Institute of Nursing Research
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R01 Clinical Trial Optional)
(PA-18-147)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R01 Clinical Trial Optional)
(PA-18-148)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional)
(PA-18-149)
National Institute of Nursing Research
National Cancer Institute
Application Receipt Date(s): Standard AIDS dates apply by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
-
Promoting Caregiver Health Using Self-Management (R01 Clinical Trial Optional)
(PA-18-150)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Chronic Condition Self-Management in Children and Adolescents (R01 Clinical Trial Optional)
(PA-18-151)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Reducing Health Disparities Among Minority and Underserved Children (R01 Clinical Trial Optional)
(PA-18-152)
National Institute of Nursing Research
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
(PA-18-155)
National Institute of Nursing Research
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Personalized Strategies to Manage Symptoms of Chronic Illness (R21 Clinical Trial Optional)
(PA-18-156)
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.,Standard dates apply by 5:00 PM local time of applicant organization
-
Innovative Questions in Symptom Science and Genomics (R21 Clinical Trial Optional)
(PA-18-157)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
-
Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional)
(PA-18-158)
National Institute of Nursing Research
National Center for Complementary and Integrative Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)
(PA-18-159)
National Institute of Nursing Research
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21 Clinical Trial Optional)
(PA-18-160)
National Institute of Nursing Research
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 16, 2018.
-
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional)
(PA-18-161)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Health Promotion Among Racial and Ethnic Minority Males (R21 Clinical Trial Optional)
(PA-18-162)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21 Clinical Trial Optional)
(PA-18-163)
National Institute of Nursing Research
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21 Clinical Trial Optional)
(PA-18-164)
National Institute of Nursing Research
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R21 Clinical Trial Optional)
(PA-18-165)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R21 Clinical Trial Optional)
(PA-18-166)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional)
(PA-18-167)
National Institute of Nursing Research
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Chronic Condition Self-Management in Children and Adolescents (R21 Clinical Trial Optional)
(PA-18-168)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional)
(PA-18-169)
National Institute of Nursing Research
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required)
(PA-18-192)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional)
(PA-18-193)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional)
(PA-18-194)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required)
(PA-18-197)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required)
(PA-18-198)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional)
(PA-18-199)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional)
(PA-18-200)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional)
(PA-18-201)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional)
(PA-18-202)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional)
(PA-18-210)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Multiple dates, see announcement.
-
NIMH Exploratory/Developmental Research Grant (R21 - Clinical Trial Not Allowed)
(PA-18-350)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Human Subjects Mechanistic and Minimal Risk Studies (R01 Clinical Trial Optional)
(PA-18-351)
National Eye Institute
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
(PAR-18-008)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)
(PAR-18-011)
National Cancer Institute
Application Receipt Date(s): February 14, 2018, June 28, 2018; October 11, 2018; February 14, 2019; June 28, 2019; October 11, 2019; February 14, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
(PAR-18-019)
National Cancer Institute
Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional)
(PAR-18-027)
National Institute on Aging
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01 Clinical Trial Optional)
(PAR-18-051)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
(PAR-18-064)
National Institute on Drug Abuse
National Cancer Institute
Application Receipt Date(s): February 8, 2018; June 8, 2018; November 8, 2018, by 5:00 PM local time of applicant organization.
-
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional)
(PAR-18-091)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21 Clinical Trial Optional)
(PAR-18-094)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03 Clinical Trial Optional)
(PAR-18-095)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional)
(PAR-18-126)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): February 5, 2018; October 5, 2018; February 5, 2019; October 5, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Selected Topics in Transfusion Medicine (R21 Clinical Trial Optional)
(PAR-18-132)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): February 16, 2018; October 16, 2018; February 16, 2019; October 16, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
(PAR-18-174)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
-
Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional)
(PAR-18-179)
National Institute on Aging
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
(PAR-18-206)
National Institute of Biomedical Imaging and Bioengineering
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Bioengineering Research Partnerships (U01 Clinical Trial Optional)
(PAR-18-208)
National Institute of Biomedical Imaging and Bioengineering
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): May 8, 2018, September 13, 2018, by 5:00 PM local time of applicant organization.
-
Transition to Independent Environmental Health Research (TIEHR) Career Transition Award (K01 Clinical Trial Required)
(PAR-18-261)
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Transition to Independent Environmental Health Research (TIEHR) Career Transition Award (K01 Clinical Trial Not Allowed)
(PAR-18-291)
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 - No Independent Clinical Trials)
(PAR-18-349)
Office of Behavioral and Social Sciences Research
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Center for Complementary and Integrative Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): March 6, 2018, and March 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
(RFA-AG-18-021)
National Institute on Aging
Application Receipt Date(s): February 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this funding opportunity announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01- Clinical Trial Optional)
(RFA-DK-17-038)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 13, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
-
Environmental Health Sciences Core Centers (EHS CC) (P30 Clinical Trial Optional)
(RFA-ES-18-003)
National Institute of Environmental Health Sciences
Application Receipt Date(s): April 17, 2018, April 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Contraception Research Centers Program (U54)
(RFA-HD-18-035)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): January 9, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) (Clinical Trial Required)
(RFA-HL-18-027)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): February 20, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed)
(RFA-MD-18-002)
National Institute on Minority Health and Health Disparities
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): February 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
(RFA-MH-18-510)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): March 15, 2018; December 7, 2018; August 7, 2019; April 7, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
-
NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33 Clinical Trial Not Allowed)
(RFA-MH-18-600)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
NIH Blueprint for Neuroscience Research
National Center for Advancing Translational Sciences
Application Receipt Date(s): January 22, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01)-Clinical Trial Not Allowed
(RFA-MH-18-610)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): January 8, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed)
(RFA-MH-18-611)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): January 8, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Translational Neural Devices (UG3/UH3 - Clinical Trial Required)
(RFA-NS-18-011)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): February 21, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020, February 22, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Translational Neural Devices (U44 - Clinical Trial Required)
(RFA-NS-18-012)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): February 21, 2018; June 21, 2018; October 22, 2018; February 21, 2019; June 21, 2019; October 21, 2019; February 21, 2020; June 22, 2020; and October 21, 2020 , February 22, 2021 by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.